Alberto Gulino Selected Research

Alberto Gulino Research Topics

Disease

44	Neoplasms (Cancer) 01/2018 - 02/2002
15	Neuroblastoma 01/2018 - 02/2002
10	Medulloblastoma 11/2019 - 08/2006
9	Carcinogenesis 01/2016 - 04/2004
6	Breast Neoplasms (Breast Cancer) 02/2016 - 09/2002
3	Colorectal Neoplasms (Colorectal Cancer) 07/2014 - 04/2004
3	Glioma (Gliomas) 01/2014 - 02/2010
3	Parkinson Disease (Parkinson's Disease) 05/2011 - 08/2002
3	Ovarian Neoplasms (Ovarian Cancer) 06/2010 - 12/2003
3	Leukemia 03/2006 - 01/2003
3	Lymphoma (Lymphomas) 03/2006 - 11/2003
2	Basal Cell Carcinoma (Rodent Ulcer) 01/2016 - 06/2010
2	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 12/2014 - 01/2003
2	Huntington Disease (Huntington's Disease) 05/2011 - 04/2008
2	Mitochondrial Diseases (Mitochondrial Disease) 05/2011 - 04/2008
2	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2010 - 04/2008
2	Retinoblastoma (Glioblastoma, Retinal) 01/2010 - 03/2009
2	Hypoxia (Hypoxemia) 09/2009 - 10/2004
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2008 - 05/2005
2	T-Cell Leukemia (Leukemia, T Cell) 02/2005 - 04/2003
1	Type 2 Diabetes Mellitus (MODY) 06/2015
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2014
1	Prostatic Neoplasms (Prostate Cancer) 01/2014
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2013
1	GATA2 Deficiency 01/2013
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2013
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2013
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2013
1	Neoplasm Metastasis (Metastasis) 01/2012

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 11/2019 - 02/2003
6	MicroRNAs (MicroRNA)IBA 01/2014 - 05/2007
6	NF-kappa B (NF-kB)IBA 04/2008 - 08/2002
5	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 09/2002
4	Messenger RNA (mRNA)IBA 02/2016 - 11/2003
4	Protein Isoforms (Isoforms)IBA 01/2013 - 12/2006
4	Matrix Metalloproteinases (MMPs)IBA 10/2011 - 08/2002
4	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2009 - 02/2002
3	HhAntag691IBA 02/2016 - 06/2010
3	LigandsIBA 01/2016 - 05/2011
3	Oncogene Proteins (Oncogene Protein)IBA 01/2014 - 02/2009
3	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 10/2012 - 05/2005
3	ErbB Receptors (EGF Receptor)IBA 10/2012 - 12/2003
3	Biomarkers (Surrogate Marker)IBA 01/2012 - 10/2005
3	nutlin 3IBA 01/2012 - 01/2011
3	Nerve Growth Factor (NGF)IBA 02/2007 - 10/2004
2	TubulinIBA 08/2015 - 08/2014
2	Notch3 ReceptorIBA 12/2014 - 04/2003
2	Antineoplastic Agents (Antineoplastics)IBA 08/2014 - 04/2011
2	Histones (Histone)IBA 08/2014 - 04/2011
2	Azacitidine (5 Azacytidine)FDA Link 02/2014 - 06/2003
2	PlasminogenIBA 07/2012 - 09/2002
2	Galectin 3 (LGALS3)IBA 01/2012 - 12/2003
2	AcidsIBA 05/2011 - 04/2008
2	UbiquitinIBA 04/2011 - 02/2007
2	Histone Deacetylase InhibitorsIBA 04/2011 - 04/2011
2	Histone Deacetylases (Histone Deacetylase)IBA 04/2011 - 04/2011
2	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2010 - 03/2009
2	Phosphotransferases (Kinase)IBA 05/2007 - 11/2003
2	Dopamine (Intropin)FDA LinkGeneric 05/2006 - 08/2002
2	HMGA ProteinsIBA 10/2005 - 09/2005
2	sodium-iodide symporter (sodium iodide symporter)IBA 07/2005 - 04/2005
2	IodidesIBA 07/2005 - 04/2005
2	Poly TIBA 12/2004 - 04/2004
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2003 - 03/2002
1	6- (4- hydroxyphenyl)- 2- thioxo- 2,3- dihydro- 4(1H)- pyrimidinoneIBA 01/2018
1	GANT 61IBA 02/2016
1	Proto-Oncogene Proteins p21(ras)IBA 02/2016
1	PolyaminesIBA 10/2015
1	Formaldehyde (Formol)FDA Link 09/2015
1	ParaffinIBA 09/2015
1	Calcibiotic Root Canal SealerIBA 09/2015
1	indoleIBA 08/2015
1	Glucose (Dextrose)FDA LinkGeneric 06/2015
1	glabrescione BIBA 01/2015
1	PyrrolesIBA 08/2014
1	Colchicine FDA LinkGeneric 08/2014
1	Growth InhibitorsIBA 08/2014
1	LuciferasesIBA 08/2014
1	VemurafenibIBA 07/2014
1	Panitumumab (Vectibix)FDA Link 07/2014
1	NucleosidesIBA 02/2014
1	EnzymesIBA 02/2014
1	MethyltransferasesIBA 02/2014
1	Decitabine FDA Link 02/2014
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 01/2014
1	Free RadicalsIBA 01/2014
1	Pyruvate KinaseIBA 01/2014
1	arseniteIBA 01/2014
1	CurcuminIBA 10/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2012
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 07/2012
1	Edetic Acid (EDTA)FDA Link 07/2012
1	pro-matrix metalloproteinase 9IBA 07/2012
1	Small Interfering RNA (siRNA)IBA 01/2012
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 01/2012
1	ThioredoxinsIBA 10/2011
1	Pioglitazone (Actos)FDA Link 05/2011

Therapy/Procedure

10	Therapeutics 01/2016 - 12/2003
2	Drug Therapy (Chemotherapy) 02/2014 - 10/2012
2	Combined Modality Therapy 01/2012 - 01/2011